These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9543371

  • 1. Adequate clinical control of congenital nephrotic syndrome by enalapril.
    Guez S, Giani M, Melzi ML, Antignac C, Assael BM.
    Pediatr Nephrol; 1998 Feb; 12(2):130-2. PubMed ID: 9543371
    [Abstract] [Full Text] [Related]

  • 2. Enalapril and prednisone in children with nephrotic-range proteinuria.
    Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.
    Pediatr Nephrol; 2000 Oct; 14(12):1088-91. PubMed ID: 11045392
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK, Varma PP, Baliga KV.
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [Abstract] [Full Text] [Related]

  • 4. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
    Lama G, Luongo I, Piscitelli A, Salsano ME.
    Clin Nephrol; 2000 Jun; 53(6):432-6. PubMed ID: 10879662
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of Supramaximal Angiotensin-converting Enzyme Inhibition in Controlling Proteinuria in Congenital Nephrotic Syndrome with Cytomegalovirus Infection and an NPHS1 Mutation.
    Dange N, Sathe KP, Kondekar A, Sawant V.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):462-467. PubMed ID: 38995307
    [Abstract] [Full Text] [Related]

  • 6. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr 01; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 7. Anaemia after enalapril in a child with nephrotic syndrome.
    Sackey AH.
    Lancet; 1998 Jul 25; 352(9124):285-6. PubMed ID: 9690411
    [No Abstract] [Full Text] [Related]

  • 8. Congenital nephrotic syndrome responsive to captopril and indometacin.
    Heaton PA, Smales O, Wong W.
    Arch Dis Child; 1999 Aug 25; 81(2):174-5. PubMed ID: 10490532
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type.
    Birnbacher R, Förster E, Aufricht C.
    Pediatr Nephrol; 1995 Jun 25; 9(3):400. PubMed ID: 7632545
    [No Abstract] [Full Text] [Related]

  • 10. Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
    Proesmans W, Wambeke IV, Dyck MV.
    Pediatr Nephrol; 1996 Oct 25; 10(5):587-9. PubMed ID: 8897561
    [Abstract] [Full Text] [Related]

  • 11. Enalapril dosage in steroid-resistant nephrotic syndrome.
    Bagga A, Mudigoudar BD, Hari P, Vasudev V.
    Pediatr Nephrol; 2004 Jan 25; 19(1):45-50. PubMed ID: 14648339
    [Abstract] [Full Text] [Related]

  • 12. Enalapril following captopril-induced nephrotic syndrome.
    Webb DJ, Atkinson AB.
    Scott Med J; 1986 Jan 25; 31(1):30-2. PubMed ID: 3008324
    [Abstract] [Full Text] [Related]

  • 13. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar 25; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 14. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.
    Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M.
    Clin Nephrol; 2002 Aug 25; 58(2):95-102. PubMed ID: 12227694
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.
    Pomeranz A, Wolach B, Bernheim J, Korzets Z, Bernheim J.
    J Pediatr; 1995 Jan 25; 126(1):140-2. PubMed ID: 7815205
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G, Mazzi A, Allegri L, Buzio C, Borghetti A.
    Miner Electrolyte Metab; 1996 Jan 25; 22(1-3):123-7. PubMed ID: 8676802
    [Abstract] [Full Text] [Related]

  • 17. A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report.
    Ishiwa S, Kamei K, Tanase-Nakao K, Shibata S, Matsunami K, Takeuchi I, Sato M, Ishikura K, Narumi S.
    BMC Nephrol; 2020 Aug 12; 21(1):340. PubMed ID: 32787808
    [Abstract] [Full Text] [Related]

  • 18. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 12; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 19. Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition.
    Sreedharan R, Bockenhauer D.
    Pediatr Nephrol; 2005 Sep 12; 20(9):1340-2. PubMed ID: 15965772
    [Abstract] [Full Text] [Related]

  • 20. Genetic Studies in Infants with Congenital Nephrotic Syndrome: A Case Series.
    Karunakar P, Chidambaram AC, Krishnamurthy S, Sivamurukan P, Deepthi B, Gowda M.
    Saudi J Kidney Dis Transpl; 2023 Mar 01; 34(2):191-195. PubMed ID: 38146730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.